Use of Acid-Suppressant Medications After Diagnosis Increases Mortality in a Subset of Gastrointestinal Cancer Patients.
Sanjana AyyagariMimi C TanYan LiuHashem B El-SeragAaron P ThriftPublished in: Digestive diseases and sciences (2019)
Post-diagnosis PPI/H2RA use was associated with the increased mortality in gastric non-cardia cancer and HCC patients.
Keyphrases
- end stage renal disease
- cardiovascular events
- ejection fraction
- newly diagnosed
- chronic kidney disease
- rheumatoid arthritis
- risk factors
- prognostic factors
- peritoneal dialysis
- type diabetes
- cardiovascular disease
- squamous cell
- coronary artery disease
- patient reported outcomes
- patient reported
- systemic sclerosis
- lymph node metastasis